nilutamide
Selected indexed studies
- Nilutamide. (, 2012) [PMID:31643487]
- Nilutamide: an antiandrogen for the treatment of prostate cancer. (Ann Pharmacother, 1997) [PMID:8997470]
- Pharmacokinetics and metabolism of nilutamide. (Urology, 1991) [PMID:1992598]
_Worker-drafted node — pending editorial review._
Connections
nilutamide is a side effect of
Sources
- Nilutamide. (2012) pubmed
- Nilutamide: an antiandrogen for the treatment of prostate cancer. (1997) pubmed
- Pharmacokinetics and metabolism of nilutamide. (1991) pubmed
- Nilutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer. (1993) pubmed
- Efficacy and Safety of Nilutamide in Patients with Metastatic Prostate Cancer who Underwent Orchiectomy: A Systematic Review and Metaanalysis. (2019) pubmed
- Castration plus nilutamide vs castration plus placebo in advanced prostate cancer. A review. (1991) pubmed
- Nilutamide. (2012) pubmed
- Antiandrogens. (2012) pubmed
- Pharmacology of nilutamide. (1993) pubmed
- Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial. (2023) pubmed